DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”
In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs
DCT Board Approves Concepts For New RFA, New And Recompeting Contracts
Major Changes In NCI Drug screening Tumor Panels Approved
Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal
Ethics Commission Say HHS Should Test Injury Compensation
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final









